PG
DXCM icon

Proffitt & Goodson’s DexCom DXCM Stock Holding History

Proffitt & Goodson’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$711K Sell
10,550
-382
-3% -$25.5K 0.1% 86
2026
Q1 		$687K Buy
10,932
+41
+0.4% +$2.85K 0.11% 80
2025
Q4 		$723K Buy
10,891
+10,875
+67,969% +$703K 0.1% 77
2025
Q3 		$1.08K Buy
+16
New +$1.27K ﹤0.01% 379

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Proffitt & Goodson's DXCM Position: Q2 2026 in Review

Proffitt & Goodson reduced its DexCom (DXCM) stake by 3.5% in Q2 2026, selling an estimated $25.5K and leaving 10,550 shares worth $711K. The position accounts for 0.1% of the portfolio, ranked #86.

Proffitt & Goodson first reported a position in DXCM in Q3 2025 and has held it in 4 quarters since. The position peaked at $723K in Q4 2025. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Proffitt & Goodson held 10,550 shares of DexCom worth $711K as of Q2 2026.
  • Proffitt & Goodson sold 382 DexCom shares in Q2 2026, an estimated $25.5K.
  • DexCom made up 0.1% of Proffitt & Goodson's portfolio in Q2 2026, its #86 holding.
  • Proffitt & Goodson first reported a position in DexCom in Q3 2025 and has held it in 4 quarters since.
  • Proffitt & Goodson's DexCom position peaked at $723K in Q4 2025.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Proffitt & Goodson's 13F filing for Q2 2026, filed 22 Jul 2026.